Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02411058 · ClinicalTrials.gov registry record · NA
Attention to Incentives
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 2,055
- Enrollment target
NCT02411058: Completed NA study, sponsored by University of Pennsylvania.
NCT02411058 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 2,055 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (46% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02411058, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,055 participants
- Enrollment target
Study Summary
In this experiment, the investigators will test the effectiveness of a two week 20x incentive multiplier on the investigators' corporate partner's users who are (a) not notified about the incentives in advance, and (b) notified about the incentives and their purpose. The investigators will test which group shows the largest boost in walking during the two week intervention and the most lasting behavior change.
Interventions
- BEHAVIORAL Uninformed
- BEHAVIORAL Informed
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,055 participants |
| Start Date | 2015-03 |
| Phase | NA |
What the finished NCT02411058 record still lists
NCT02411058 is an interventional study that assigns participants to a tested intervention. Its 2,055 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (46% higher).
The record links to 0 conditions, and to 2 interventions - of which Uninformed is the first listed.
NCT02411058 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02411058 about?
NCT02411058 is a clinical study titled "Attention to Incentives". In this experiment, the investigators will test the effectiveness of a two week 20x incentive multiplier on the investigators' corporate partner's users who are (a) not notified about the incentives in advance, and (b) notified about the incentives and their purpose. The investigators will test whic...
What is the current status of trial NCT02411058?
This trial is currently completed. It is a NA study. The enrollment target is 2,055 participants. The study started on 2015-03.
What interventions are being tested in trial NCT02411058?
The interventions under investigation include: Uninformed (BEHAVIORAL), Informed (BEHAVIORAL).
Who is sponsoring clinical trial NCT02411058?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02411058's enrollment target sits among peer trials
2,055 51st of 2000 higher than 1,950 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05050084 · 2,050 participants · Phase 3
Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial
- NCT05688982 · 2,049 participants · NA
MOLAR: Mapping Oral Health and Local Area Resources
- NCT04871542 · 2,062 participants
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
- NCT06521944 · 2,062 participants
RSV Vaccine Pregnancy Registry
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia